Clinical trial

Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing

NCT03612817

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-01

PhasePHASE4

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2020-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Open-Angleunresolved

Interventions

Tafluprost/timolol fixed combinationDRUG

Sponsors & collaborators

Aristotle University Of Thessalonikilead sponsor

Santen Oycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03612817 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.